User profiles for D. Piccioni

Davide Colombi

Ericsson Research
Verified email at ericsson.com
Cited by 1336

[HTML][HTML] First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

…, AB Etame, D Mathieu, S Kesari, D Piccioni… - Journal of translational …, 2018 - Springer
Background Standard therapy for glioblastoma includes surgery, radiotherapy, and
temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed …

Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies

…, T Dentamaro, L Cupelli, A Tendas, D Piccioni… - Bone marrow …, 2008 - nature.com
Severe pain syndromes may be recorded during all phases of haematopoietic stem cell
transplantation (HSCT) for haematological malignancies: from stem cell mobilization to the long-…

Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a …

…, AB Etame, S Kesari, D Mathieu, DE Piccioni… - JAMA …, 2023 - jamanetwork.com
Importance Glioblastoma is the most lethal primary brain cancer. Clinical outcomes for
glioblastoma remain poor, and new treatments are needed. Objective To investigate whether …

Assessment of human exposure to electromagnetic fields: Review and future directions

…, T Onishi, K Sasaki, S Ahn, D Colombi… - IEEE Transactions …, 2021 - ieeexplore.ieee.org
… The 3-D electric field distribution can then be estimated based on the 2-D SAR measurement
by the array (eg, [64], [65]). The abovementioned procedures do not apply to devices …

Measurement of theF 2 structure function in deep inelastice + p scattering using 1994 data from the ZEUS detector at HERA

…, ME Hayes, GP Heath, HF Heath, D Piccioni… - Zeitschrift für Physik C …, 1996 - Springer
We present measurements of the structure functionF 2 ine + p scattering at HERA in the
range 3.5 GeV 2 <Q 2 <5000 GeV 2 . A new reconstruction method has allowed a significant …

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

…, ME Hahn, CB Williams, P De, A Krie, DE Piccioni… - Nature medicine, 2019 - nature.com
d, Bar graph showing the percentage of patients with a PFS ratio ≥1.3 or <1.3 among patients
with a matching score of ≤50% (N = 49) versus >50% (N = 20). P values were computed …

Measurement of the proton structure function F2 at very low Q2 at HERA

…, B Foster, GP Heath, HF Heath, JD McFall, D Piccioni… - Physics Letters B, 2000 - Elsevier
A measurement of the proton structure function F 2 (x,Q 2 ) is presented in the kinematic range
0.045 GeV 2 <Q 2 <0.65 GeV 2 and 6·10 −7 <x<1·10 −3 . The results were obtained using …

Prevalence of PDL1 amplification and preliminary response to immune checkpoint blockade in solid tumors

AM Goodman, D Piccioni, S Kato, A Boichard… - JAMA …, 2018 - jamanetwork.com
Importance Copy number alterations in programmed cell death ligand 1 (PDL1orCD274),
programmed cell death 1 ligand 2 (PDCD1LG2orPDL2), and Janus kinase 2 (JAK2) genes (…

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

…, T Mikkelsen, PL Nghiemphu, D Piccioni… - Science translational …, 2016 - science.org
Toca 511 (vocimagene amiretrorepvec) is an investigational nonlytic, retroviral replicating
vector (RRV) that delivers a yeast cytosine deaminase, which converts subsequently …

Comparison of ZEUS data with standard model predictions for e+p → e+X scattering at high x and Q2

…, ME Hayes, GP Heath, HF Heath, D Piccioni… - Zeitschrift für Physik C …, 1997 - Springer
Using the ZEUS detector at HERA, we have studied the reaction e + p → e + X for Q 2 >
5000 GeV 2 with a 20.1 pb −1 data sample collected during the years 1994 to 1996. For Q 2 …